The PE Ratio as of December 2025 (TTM) for Lukas Biomedical Inc. (6814.TWO) is -13.72

According to Lukas Biomedical Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -13.72. This represents a change of 101.17% compared to the average of -6.82 of the last 4 quarters.

Lukas Biomedical Inc. (6814.TWO) Historical PE Ratio (quarterly & annually)

How has 6814.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Lukas Biomedical Inc. over the last ten years is -83.70. The current -13.72 PE Ratio has changed 1.54% with respect to the historical average. Over the past ten years (40 quarters), 6814.TWO's PE Ratio was at its highest in in the June 2025 quarter at -5.20. The PE Ratio was at its lowest in in the June 2019 quarter at -126.62.

Lukas Biomedical Inc. (6814.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lukas Biomedical Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lukas Biomedical Inc. (6814.TWO) Average PE Ratio

How has 6814.TWO PE Ratio performed in the past?

The current PE Ratio of Lukas Biomedical Inc. (6814.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lukas Biomedical Inc. (6814.TWO) PE Ratio vs. Peers

How is 6814.TWO’s PE Ratio compared to its peers?

Lukas Biomedical Inc.’s PE Ratio is less than Bio Preventive Medicine Corp. (-12.05), less than LabTurbo Biotech Corporation (-7.06), less than LAUNXP Biomedical Co., Ltd (-6.64), less than MegaPro Biomedical Co., Ltd (-5.63), less than Level Biotechnology Inc. (15.68), less than Taiwan Advance Bio-Pharmaceutical Inc. (44.82), less than GeneReach Biotechnology Corp. (-7.89), less than Andros Pharmaceuticals Co.,Ltd (-12.62), greater than Great Novel Therapeutics Biotech & Medicals (-16.86), greater than Neith Corporation (-1587.08),

Build a custom stock screener for Lukas Biomedical Inc. (6814.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lukas Biomedical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lukas Biomedical Inc. (6814.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lukas Biomedical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.